What's new

Human medicines European public assessment report (EPAR): Karvezide, irbesartan,hydrochlorothiazide, Date of authorisation: 16/10/1998, Revision: 50, Status: Authorised

Human medicines European public assessment report (EPAR): Karvezide, irbesartan,hydrochlorothiazide, Date of authorisation: 16/10/1998, Revision: 50, Status: Authorised

Feb 11, 2025 - 17:06
 0
Human medicines European public assessment report (EPAR): Karvezide, irbesartan,hydrochlorothiazide, Date of authorisation: 16/10/1998, Revision: 50, Status: Authorised
Human medicines European public assessment report (EPAR): Karvezide, irbesartan,hydrochlorothiazide, Date of authorisation: 16/10/1998, Revision: 50, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): CoAprovel, irbesartan,...

Next Article

Microsoft and EDPR sign VPPAs for 389MW of US solar capacity

Related Posts

Summary of opinion: Rinvoq, 27/02/2025 Positive

Summary of opinion: Rinvoq, 27/02/2025 Positive

Feb 28, 2025  0

Human medicines European public assessment report (EPAR): Sitagliptin SUN, sitagliptin fumarate, Date of authorisation: 09/12/2021, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025  0

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – May 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 21 May 2025, 10:00 (CEST) to 21 May 2025, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025  0